From UN:

Annan Opening Annan Statement

IAVI Statement Presented At Conference:IAVI Statement Executive Summary Of Report Report


/index.php?option=com_iwpfile&file=/dir_04/he2004_1598.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_1597.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_1596.pdf

Study Evaluates Effectiveness Of LEXIVA/ritonavir And Lopinavir/ritonavir In Protease Inhibitor (PI)- Experienced Patients 48-Week Efficacy Comparison Of LEXIVA/Ritonavir QD Vs. Nelfinavir BID In Therapy-Naïve HIV+ Patients

/index.php?option=com_iwpfile&file=/dir_04/he2004_1594.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_1593.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_1592.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_1591.pdf

St Jude Approval Info St Jude Approval Letter

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.